| Issuer | % of Class | Filed |
|---|---|---|
|
Cyabra Inc.
13G
CYAB · 23249H105
|
8.3% |
9/22/2026
Event 9/8/2026
|
|
Nuvve Holding Corp.
13G
NVVE · 67079Y506
|
10.0% |
7/20/2026
Event 7/16/2026
|
|
PLUS THERAPEUTICS, Inc.
13G/A
Amendment 1
PSTV · 72941H509
|
0% |
6/25/2025
Event 6/24/2025
|
|
Plus Therapeutics, Inc.
13G
PSTV · 72941H509
|
8.3% |
5/22/2025
Event 5/19/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.